Abbott reports fourth-quarter and full-year 2023 results; issues 2024 financial outlook

Fourth-quarter reported sales increased 1.5 percent; organic sales growth for the underlying base business increased 11.0 percent full-year 2023 reported sales decreased 8.1 percent due to anticipated decline in covid-19 testing-related sales; organic sales growth for the underlying base business increased 11.6 percent full-year 2023 gaap diluted eps of $3.26; adjusted diluted eps of $4.44 r&d pipeline continues to deliver steady cadence of new products abbott park, ill., jan. 24, 2024 /prnewswire/ -- abbott today announced financial results for the fourth quarter ended dec. 31, 2023.
ABT Ratings Summary
ABT Quant Ranking